Oppenheimer & Co. Inc. raised its position in Danaher Corporation (NYSE:DHR) by 4.9% during the first quarter, according to its most recent filing with the SEC. The firm owned 34,021 shares of the conglomerate’s stock after buying an additional 1,603 shares during the period. Oppenheimer & Co. Inc.’s holdings in Danaher Corporation were worth $2,910,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Lee Danner & Bass Inc. boosted its position in Danaher Corporation by 0.4% in the first quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock worth $225,000 after buying an additional 10 shares during the last quarter. Rehmann Capital Advisory Group boosted its position in Danaher Corporation by 0.6% in the first quarter. Rehmann Capital Advisory Group now owns 2,959 shares of the conglomerate’s stock worth $253,000 after buying an additional 19 shares during the last quarter. Alpha Windward LLC boosted its position in Danaher Corporation by 0.8% in the first quarter. Alpha Windward LLC now owns 2,605 shares of the conglomerate’s stock worth $223,000 after buying an additional 21 shares during the last quarter. Guardian Life Insurance Co. of America boosted its position in Danaher Corporation by 1.0% in the first quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock worth $202,000 after buying an additional 24 shares during the last quarter. Finally, Assetmark Inc. boosted its position in Danaher Corporation by 0.5% in the first quarter. Assetmark Inc. now owns 6,622 shares of the conglomerate’s stock worth $566,000 after buying an additional 30 shares during the last quarter. Hedge funds and other institutional investors own 76.56% of the company’s stock.
Danaher Corporation (DHR) traded up 0.67% during midday trading on Friday, reaching $79.82. The company had a trading volume of 2,433,944 shares. The company has a 50-day moving average of $82.89 and a 200-day moving average of $84.21. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The stock has a market capitalization of $55.45 billion, a PE ratio of 25.48 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. During the same period in the previous year, the company posted $0.90 earnings per share. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, analysts predict that Danaher Corporation will post $3.95 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This story was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://stocknewstimes.com/2017/08/12/danaher-corporation-dhr-shares-bought-by-oppenheimer-co-inc.html.
A number of brokerages have recently weighed in on DHR. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $88.00 target price (down from $89.00) on shares of Danaher Corporation in a research report on Friday, April 21st. BidaskClub lowered Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Zacks Investment Research lowered Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Citigroup Inc. set a $96.00 target price on Danaher Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Finally, Janney Montgomery Scott lowered Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $91.76.
In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the sale, the insider now directly owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider William King sold 7,458 shares of the business’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now directly owns 18,245 shares in the company, valued at $1,513,787.65. The disclosure for this sale can be found here. Insiders sold 38,623 shares of company stock worth $3,206,426 over the last three months. Corporate insiders own 12.20% of the company’s stock.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.